Regulatory Information
-
Prescription Drug Marketing Act Report to Congress (June 2001)
Report to Congress
Department of Health and Human Services
U.S. Food and Drug Administration
June 2001
Printer-friendly PDF version of this report (3252 KB)
-
Table of Contents
Executive Summary I. Introduction and II. Background III. Analysis of Public Comments IV. Agency Conclusions V. Decision to Further Delay the Effective Date Attachment A: List of Presenters at the Hearing Attachment B: List of Agency Panel Members at the Hearing Attachment C: List of Key Dates - Attachment D: Notice Announcing the October 27, 2000, Hearing
Attachment E: The 1988 Guidance Letter Attachment F: Questions on PDMA for the Primary Wholesalers Attachment G: Profile of the Prescription Drug Wholesaling Industry
-
-
-
